Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX) Quickview (CASRN 2691-41-0)
Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of toxicity data by U.S. EPA health scientists from several Program Offices, Regional Offices, and the Office of Research and Development.
Disclaimer: This QuickView represents a snapshot of key information. We suggest that you read the IRIS Summary to put this information into complete context.
For definitions of terms in the IRIS Web site, refer to the IRIS Glossary.
Status of Data for Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX)
File First On-Line: 09/26/1988; Last Significant Revision: 03/01/1989
Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX) Source Documents
Chronic Health Hazard Assessments for Noncarcinogenic Effects
* The Point of Departure listed serves as a basis from which the Oral RfD was derived. See Discussion of Conversion Factors and Assumptions for more details.
Not Assessed under the IRIS Program.
Carcinogenicity Assessment for Lifetime Exposure
Quantitative Estimate of Carcinogenic Risk from Oral Exposure
Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure